Similar articles

• Effect of neoadjuvant androgen deprivation on circulating prostate cells in the bone marrow of men undergoing radical prostatectomy.

  Wood DP Jr, Beaman A, Banerjee M, Powell I, Pontes E, Cher ML. Wood DP Jr, et al. Clin Cancer Res. 1998 Sep;4(9):2119-23. Clin Cancer Res. 1998. PMID: 9748128
• Endocrine treatment of prostate cancer.

  Tammela T. Tammela T. J Steroid Biochem Mol Biol. 2004 Nov;92(4):287-95. doi: 10.1016/j.jsbmb.2004.10.005. Epub 2004 Dec 31. J Steroid Biochem Mol Biol. 2004. PMID: 15663992 Review.
• Carcinoma of the prostate: neoadjuvant hormonotherapy followed by radiotherapy.

  Scalliet P. Scalliet P. Acta Urol Belg. 1996 May;64(2):63-4. Acta Urol Belg. 1996. PMID: 8701815 No abstract available.
• Neoadjuvant total androgen suppression and radiotherapy in the management of locally advanced prostate cancer.

  Roach M 3rd. Roach M 3rd. Semin Urol Oncol. 1996 May;14(2 Suppl 2):32-7; discussion 38. Semin Urol Oncol. 1996. PMID: 8725889 Review.
• [Hormone therapy of locally advanced and metastatic prostate carcinoma].

  Rübben H. Rübben H. Praxis (Bern 1994). 2001 Sep 20;90(38):1641-4. Praxis (Bern 1994). 2001. PMID: 11675917 German.